Drug Type Single-domain antibody |
Synonyms BET201 01, BET201-01, BET20101 |
Target |
Mechanism CLDN18.2 inhibitors(Claudin 18.2 inhibitors), PDL1 inhibitors(Programmed death-ligand 1 inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Preclinical | CN | - | |
Stomach Cancer | Preclinical | CN | - |